Incidence and outcomes of adverse drug reactions to first‐line anti‐tuberculosis drugs and their effects on the quality of life: A multicenter prospective cohort study-Reference-Cited by-同舟云学术

Incidence and outcomes of adverse drug reactions to first‐line anti‐tuberculosis drugs and their effects on the quality of life: A multicenter prospective cohort study

Published:2022-08-09 Issue:11 Volume:31 Page:1153-1163
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiology and Drug

Author:

Choi Hayoung¹²^ORCID,Park Hang A.³^ORCID,Hyun In Gyu²⁴^ORCID,Kim Joo‐Hee²⁵^ORCID,Hwang Yong‐Il²⁵^ORCID,Jang Seung Hun²⁵^ORCID,Sim Yun Su¹²^ORCID,Shin Tae Rim¹²^ORCID,Ko Yousang²⁶^ORCID,Ban Ga Young²⁶^ORCID,Hong Ji Young²⁷^ORCID,Lee Chang Youl²⁷^ORCID,Lee Myung Goo²⁷^ORCID,Choi Jeong‐Hee²⁴^ORCID

Affiliation:

1. Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine Hallym University Kangnam Sacred Heart Hospital Seoul South Korea

2. Lung Research Institute, Hallym University College of Medicine Chuncheon South Korea

3. Department of Emergency Medicine Hallym University Dongtan Sacred Heart Hospital Hwaseong South Korea

4. Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine Hallym University Dongtan Sacred Heart Hospital Hwaseong South Korea

5. Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine Hallym University Sacred Heart Hospital Anyang South Korea

6. Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine Kangdong Sacred Heart Hospital Seoul South Korea

7. Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine Hallym University Chuncheon Sacred Heart Hospital Chuncheon South Korea

Funder

Ministry of Food and Drug Safety

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.5513

Reference37 articles.

1. World Health Organization.Global Tuberculosis Report 2020;2020.

2. Nosocomial exposure to tuberculosis: a snapshot of South Korea

3. Management of adverse reactions to first-line tuberculosis antibiotics

4. Incidence and risk factors of major toxicity associated to first‐line antituberculosis drugs for latent and active tuberculosis during a period of 10 years;Castro AT;Rev Port Pneumol,2006

5. Home-based Anti-Tuberculosis Treatment Adverse Reactions (HATTAR) study: a protocol for a prospective observational study

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medication-related burden and its association with medication adherence among elderly tuberculosis patients in Guizhou, China: a cross-sectional study;Frontiers in Pharmacology;2024-08-29

2. A Nanopore Sequencing-based Pharmacogenomic Panel to Personalize Tuberculosis Drug Dosing;American Journal of Respiratory and Critical Care Medicine;2024-06-15

3. Evaluation of adverse reactions induced by anti-tuberculosis drugs among hospitalized patients in Wuhan, China: A retrospective study;Medicine;2024-05-17

4. A Nanopore sequencing-based pharmacogenomic panel to personalize tuberculosis drug dosing;2023-09-10

5. Clinical standards for the management of adverse effects during treatment for TB;The International Journal of Tuberculosis and Lung Disease;2023-07-01